Literature DB >> 17003955

Inhibition of tumour necrosis factor-alpha in patients with chronic hepatitis C infection.

C Zavos, J Kountouras, N Zavos, D Chatzopoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003955     DOI: 10.1007/s10067-006-0437-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  5 in total

Review 1.  Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach.

Authors:  Debbie M Nathan; Peter W Angus; Peter R Gibson
Journal:  J Gastroenterol Hepatol       Date:  2006-09       Impact factor: 4.029

2.  Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection.

Authors:  Frank A Parke; John D Reveille
Journal:  Arthritis Rheum       Date:  2004-10-15

Review 3.  Apoptosis in hepatitis C.

Authors:  J Kountouras; C Zavos; D Chatzopoulos
Journal:  J Viral Hepat       Date:  2003-09       Impact factor: 3.728

4.  Long-term outcome of hepatitis C infection after liver transplantation.

Authors:  E J Gane; B C Portmann; N V Naoumov; H M Smith; J A Underhill; P T Donaldson; G Maertens; R Williams
Journal:  N Engl J Med       Date:  1996-03-28       Impact factor: 91.245

5.  Inhibition of TNFalpha does not induce viral reactivation in patients with chronic hepatitis C infection: two cases.

Authors:  S Aslanidis; T Vassiliadis; A Pyrpasopoulou; I Douloumpakas; C Zamboulis
Journal:  Clin Rheumatol       Date:  2006-08-19       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.